Patents by Inventor Yumei XU

Yumei XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11970728
    Abstract: The present application discloses a method for rapidly identifying the resistance of wheat to black point disease caused by Bipolaris sorokiniana, where testing takes places in an indoor, controlled environment. The test method includes surface sterilization of wheat seeds, and cultivating wheat seedlings from the sterilized wheat seeds; preparing conidial suspension of Bipolaris sorokiniana, and spraying the conidial suspension on the seedlings at one-leaf-one-shoot stage; recording the percentage of the diseased leaf area in total leaf area of the first leaf of the wheat seedling on the 10th day of inoculation; calculating the black point incidence of the wheat according to an equation, and then evaluating the resistance of wheat to black point disease caused by Bipolaris sorokiniana through the black point incidence.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: April 30, 2024
    Assignee: Henan Agricultural University
    Inventors: Qiaoyun Li, Guihong Yin, Haiyong Li, Yumei Jiang, Jishan Niu, Mengyu Li, Siyu Wang, Kaige Xu
  • Patent number: 11512056
    Abstract: A P2Y12 receptor antagonist containing a guanidyl, and a preparation method and the use thereof. In particular, the present disclosure provides a pyridazinone-guanidine compound that is a compound of structural formula (I), or a stereoisomer of the above-mentioned compound, a pro-drug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof. Such a compound has multiple pharmacological activities, especially has an inhibitory effect on platelet aggregation, and can be used for preparing an anti-platelet aggregation pharmaceutical composition.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: November 29, 2022
    Assignee: Anhui New Star Pharmaceutical Development Co., Ltd
    Inventors: Xiaoxiang Li, Ziao Xu, Degang Li, Yumei Xu, Yonghai Zhao, Genling Jiang
  • Publication number: 20210078954
    Abstract: A P2Y12 receptor antagonist containing a guanidyl, and a preparation method and the use thereof. In particular, the present disclosure provides a pyridazinone-guanidine compound that is a compound of structural formula (I), or a stereoisomer of the above-mentioned compound, a pro-drug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof. Such a compound has multiple pharmacological activities, especially has an inhibitory effect on platelet aggregation, and can be used for preparing an anti-platelet aggregation pharmaceutical composition.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Inventors: Xiaoxiang LI, Ziao XU, Degang LI, Yumei XU, Yonghai ZHAO, Genling JIANG